Prevalence of vancomycin-resistant enterococcus fecal colonization among kidney transplant patients

BMC Infectious Diseases

Volumn 6, Issue , 2006, Pages

  Freitas, Maria Cecília S ^a   Pacheco Silva, Alvaro ^a   Barbosa, Dulce ^a   Silbert, Suzane ^a   Sader, Hélio ^a   Sesso, Ricardo ^a   Camargo, Luis Fernando A ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZATHIOPRINE; CEFALOTIN; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOSPORIN; GANCICLOVIR; GENTAMICIN; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; STREPTOMYCIN; TACROLIMUS; TEICOPLANIN; THYMOCYTE ANTIBODY; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CORRELATION ANALYSIS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DRUG MEGADOSE; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FECES ANALYSIS; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT REJECTION; HEMODIALYSIS; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; URINARY TRACT INFECTION; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ADULT; ENTEROCOCCUS; FECES; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PREVALENCE; VANCOMYCIN RESISTANCE;

EID: 33748357505     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-6-133     Document Type: Article

References (24)

1. Maraha B, Bonten H, Van Hooff H, Fiolet H, Buiting AG, Stobberingh EE: Infectious complications and antibiotic use in renal transplant recipients during a 1-year follow-up. Clin Microbiol Infect 2001, 7:619-625.
2. Uttley AH, George RC, Naidoo J, Woodford N, Johnson AP, Collins CH, Morrison D, Gilfillan AJ, Fitch LE, Heptonstall J: High-level vancomycin-resistant enterococci causing hospital infections. Epidemiol Infect 1989, 103:173-181.
3. Hagen EA, Lautenbach E, Olthoff K, Blumberg EA: Low prevalence of colonization with vancomycin-resistant Enterococcus in patients awaiting liver transplantation. Am J Transplant 2003, 3:902-905.
4. Bakir M, Bova JL, Newell KA, Millis JM, Buell JF, Arnow PM: Epidemiology and clinical consequences of vancomycin-resistant enterococci in liver transplant patients. Transplantation 2001, 72:1032-1037.
5. Grayson ML, Grabsch EA, Johnson PD, Olden D, Aberline M, Li HY, Hogg G, Abbott M, Kerr PG: Outcome of a screening program for vancomycin-resistant enterococci in a hospital in Victoria. Med J Aust 1999, 171:133-136.
6. Facklam R, Sham DA, Teixeira LM: Enterococcus. In Manual of Clinical of Microbiology 7th edition. Edited by: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH. Washington: American Society of Microbiology, 1999:297-305.
7. NCCLS - National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. National Committee for Clinical Laboratory Standards. Wayne 2003. Approved Standart M100-S13.
8. Barbosa D, Lima L, Silbert S, Sader H, Cendoroglo M, Draibe S, Camargo L, Vianna L, Belasco A, Sesso R: Evaluation of the prevalence and risk factors for colonization by vancomycin-resistant Enterococcus among patients on dialysis. Am J Kidney Dis 2004, 44:337-343.
9. Byers KE, Anglim AM, Anneski CJ, Farr BM: Duration of colonization with vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol 2002, 23:207-211.
10. Fridkin SK, Edwards JR. Courval JM, Hill H, Tenover FC, Iawton R, Gaynes RP, McGowan JE Jr, Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Project and the National Nosocomial Infections Surveillance (NNIS) System Hospitals: The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units. Ann Intern Med 2001, 135:175-183.
11. Camargo LFA, Lamblet LC, Magalhães VD, Martino MDV, Laselva CR, Vallone C, Marra AR, Knobell E: Higher prevalence of polyclonal vancomycin resistant E.gallinarum in surveillance cultures from a general ICU in Brazil. [Poster no. 43]. In Interscience Conference on Antimicrobial Agents and Chemotherapy Chicago; 2003.
12. Iwen PC, Kelly DM, Linder J, Hinrichs SH: Revised approach for identification and detection of ampicillin and vancomycin resistance in Enterococcus species by using MicroScan panels. J Clin Microbial 1996, 34:1779-1783.
13. Togneri A, Lopardo H, Corso A: Bacteremia par Enterococcus gallinarum con alto nivel de resistencia a glicopépdidos: primer caso documentado en Argentina. Rev Argent Microbiol 2003, 35:96-99.
14. Ruess M, Sander A, Hentschel R, Berner R: Enterococcus casseliflavus septicaemia in a preterm neonate. Scand J Infect Dis 2002, 34:471-472.
15. Reid KC, Cockerill FR III, Patel R: Clinical and epidemiological features of Enterococcus casseliflavus/flavescens and Enterococcus gallinarum bacteremia: a report of 20 cases. Clin Infect Dis 2001, 32:1540-1546.
16. Montecalvo MA, Shay DK, Patel P, Tacsa L, Maloney SA, Jarvis WR, Wormser GP: Bloodstream infections with vancomycin-resistant enterococci. Arch Intern Med 1996, 156:1458-1462.
17. Tokars JI, Gehr T, Jarvis WR, Anderson J, Armistead N, Miller ER, Parrish J, Qaiyumi S, Arduino M, Holt SC, Tenover FC, Westbrook G, Light P: Vancomycin-resistant enterococci colonization in patients at seven hemodialysis centers. Kidney Inter 2001, 60:1511-1516.
18. Papanicolaou GA, Meyers BR, Meyers J, Mendelson MH, Lou W, Emre S, Sheiner P, Miller C: Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality. Clin Infect Dis 1996, 23:760-766.
19. Orloff SL, Busch AMH, Olyaei AJ, Corless CL, Benner KG, Flora KD, Rosen HR, Rabkin JM: Vancomycin-resistant Enterococcus in liver transplant patients. Am J Surgery 1999, 177:418-422.
20. Vincenti F, Amend W, Feduska NJ, Duca RM, Salvatierra O Jr: Improved outcome following renal transplantation with reduction in the immunosuppression therapy for rejection episodes. Am J Med 1980, 69:107-112.
21. Mayes JT, Thistlethwaite JR Jr, Stuart JK, Buckingham MR, Stuart FP: Reexposure to OKT3 in renal allograft recipients. Transplantation 1988, 45:349-353.
22. von Baum H, Schehl J, Geiss HK, Schaefer F, and the Mid-European Pediatric Peritoneal Dialysis Study Group: Prevalence of vancomycin-resistant enterococci among children with end-stage renal failure. Clin Infect Dis 1999, 29:912-916.
23. McNeil SA, Malani PN, Chenoweth CE, Fontana RJ, Magee JC, Punch JD, Mackin ML, Kauffman CA: Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients: A prospective surveillance study. Cin Infect Dis 2006, 42:195-203.
24. Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP, Shah S, Rudrik JT, Pupp GR, Brown WJ, Cardo D, Fridkin SK, Vancomycin-Resistant Staphylococcus aureus Investigative Team: Infection with vancomycin-resistant Staphylococcus aureus containing the van A resistance gene. N Engl J Med 2003, 348:1342-1347.